Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Brno-Stred

328 clinical trials in Brno-Stred, Czechia across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Brno-Stred at a glance
328
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

328 trials in Brno-Stred

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Dextromethorphan Hydrobromide
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Summit Therapeutics Inc.

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Brno-Stred

What the registry says about research in the country

01 Brno-Stred
Cardiovascular Disease and Metabolic Risk
In Brno-Stred, many trials focus on heart and blood vessel health, including heart failure, myocardial infarction, atrial fibrillation, atherosclerotic cardiovascular disease, and lipid disorders. The studies are largely aimed at testing new treatments, lowering cardiovascular risk, and improving outcomes after major cardiac events. Heart failure and prevention of worsening symptoms Myocardial infarction, stroke prevention, and post-event recovery Dyslipidemia, elevated Lp(a), and hypercholesterolemia Obesity, hypertension, and broader cardiometabolic risk These trials also explore whether newer therapies can reduce inflammation and help prevent future cardiovascular complications.
Oncology and Hematologic Malignancies
Cancer research is a major part of the trial activity, covering breast cancer, lung cancer, ovarian cancer, prostate cancer, colorectal cancer, and several other advanced solid tumors. The main goal is to evaluate new cancer therapies, improve survival, and refine treatment options for difficult-to-treat disease. Breast cancer, including hormone receptor-positive and triple-negative disease Prostate cancer, renal cell carcinoma, and urothelial cancer Ovarian, cervical, endometrial, and gastric cancers Melanoma, lung cancer, and other advanced solid tumors Many studies in the city are centered on immunotherapy, targeted treatment, and better maintenance strategies after standard therapy.
Neurology and Psychiatry
Clinical trials in this area address multiple sclerosis, Alzheimer’s disease, Parkinson disease, epilepsy, and mood or psychotic disorders linked to neurodegeneration. Researchers are seeking better symptom control, disease modification, and improved quality of life for patients with chronic brain and nervous system conditions. Multiple sclerosis and related inflammatory nervous system disease Alzheimer’s disease with agitation, psychosis, or early-stage cognitive decline Epilepsy and refractory seizure disorders Parkinson disease and other movement-related conditions Several studies also examine brain inflammation and new approaches to managing neuropsychiatric symptoms.
Immune-Mediated and Inflammatory Diseases
Another strong research theme involves autoimmune and inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, psoriasis, and atopic dermatitis. These trials are designed to assess whether newer therapies can better control inflammation and reduce disease flares. Rheumatoid arthritis and axial spondyloarthritis Crohn’s disease and ulcerative colitis Psoriasis, atopic dermatitis, and chronic urticaria Lupus and other immune system diseases These studies often compare newer immune therapies with existing treatment approaches to improve long-term disease control.
Respiratory and Infectious Diseases
Trials in this group include studies on asthma, severe pneumonia, influenza, respiratory distress syndrome, and bacterial or viral infections. The research aims to improve prevention, reduce complications, and test treatments for serious infections affecting the lungs and airways. Asthma and other chronic respiratory conditions Severe pneumonia and acute respiratory distress syndrome Influenza prevention in older adults Bacterial infections, mycoses, and wound-related infection Some studies also look at faster recovery and better protection against infection-related complications.
Digestive System and Metabolic Disorders
There is broad activity around digestive diseases and metabolism, including obesity, type 2 diabetes, gout, and hypertriglyceridemia. Several trials focus on improving symptom control, metabolic balance, and cardiovascular risk linked to these chronic conditions. Type 2 diabetes and weight-related complications Gout with elevated uric acid Crohn’s disease and ulcerative colitis Gastrointestinal cancers such as gastric and colorectal cancer These studies combine treatment evaluation with a strong focus on long-term disease management.
Musculoskeletal and Pain Research
Trials in this field address osteoarthritis, rheumatoid arthritis, axial spondyloarthritis, osteoporosis, and chronic pain conditions. The main objective is to ease pain, preserve function, and improve daily mobility for people with long-term joint and bone disorders. Knee osteoarthritis and chronic joint pain Rheumatoid arthritis and inflammatory joint disease Postmenopausal osteoporosis Chronic low back pain and psoriatic arthritis Research here often compares symptom relief strategies and looks for safer, more durable pain control.
Urology, Gynecology, and Reproductive Health
Several trials focus on diseases affecting the urinary and reproductive systems, including prostate cancer, bladder cancer, endometrial cancer, ovarian cancer, and endometriosis. The studies aim to improve treatment effectiveness, symptom relief, and reproductive health outcomes. Prostate cancer and bladder cancer Ovarian, endometrial, and cervical cancer Endometriosis and primary dysmenorrhea Contraception and pregnancy-related prevention studies Some of the research also supports better management of hormone-related and pelvic pain conditions.
Rare Diseases and Cardiomyopathies
The city also hosts trials in less common conditions such as transthyretin amyloid cardiomyopathy, primary immunodeficiency diseases, hereditary angioedema, and myelofibrosis. These studies are typically aimed at testing new therapies for diseases with limited treatment options. ATTR-CM and other amyloid-related heart disorders Primary immunodeficiency diseases Hereditary angioedema Myelofibrosis and Langerhans cell histiocytosis Such trials are especially important for patients who need more targeted care in specialized disease areas.
Dermatology and Allergy
Research in skin and allergic diseases includes atopic dermatitis, chronic spontaneous urticaria, bullous pemphigoid, and seasonal allergic rhinitis. The purpose is to evaluate new ways to control itching, inflammation, and persistent allergic symptoms. Atopic dermatitis and chronic eczema-related disease Chronic spontaneous urticaria Bullous pemphigoid Allergic rhinitis and rhinoconjunctivitis These studies aim to improve comfort and reduce the burden of recurring skin and allergy symptoms.
Vascular and Thrombotic Disorders
Several trials are directed at stroke, venous thromboembolism, pulmonary embolism, and other clot-related conditions. The research is focused on prevention, better treatment after acute events, and reducing the risk of recurrence. Ischemic stroke and high-risk transient ischemic attack Venous thromboembolism and pulmonary embolism Atrial fibrillation with stroke prevention Acute coronary syndromes linked to clot risk These studies often examine whether newer medicines can offer safer long-term protection against major vascular events.
General Internal Medicine and Supportive Care
In addition to disease-specific work, there are trials addressing broader clinical problems such as sepsis, acute kidney injury, wound infection, urinary incontinence, and other pathological conditions. This research supports better management of complex patients across multiple specialties in Czechia. Sepsis-associated acute kidney injury Complicated surgical and traumatic wound infections Urinary incontinence and related symptoms General supportive care in medically complex illness Overall, the trial portfolio in the city reflects a strong mix of prevention, treatment testing, and disease-management research.
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).